Annual report pursuant to Section 13 and 15(d)

Equity Method Investments - Summary of Financial Information (Details)

v3.23.1
Equity Method Investments - Summary of Financial Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Feb. 28, 2023
Feb. 28, 2022
Feb. 28, 2021
Schedule of Equity Method Investments [Line Items]          
Current assets $ 3,496.1 $ 3,329.7 $ 3,496.1 $ 3,329.7  
Current liabilities 2,968.3 2,698.8 2,968.3 2,698.8  
Noncontrolling interests 320.3 315.9 320.3 315.9  
Net sales 1,997.8 2,102.5 9,452.6 8,820.7 $ 8,614.9
Gross profit (loss) 961.2 1,132.6 4,769.0 4,707.3 4,466.0
Net income (loss)     (38.5) 1.0 2,031.8
Net income (loss) attributable to CBI 223.0 395.4 (71.0) (40.4) 1,998.0
Canopy equity method investment          
Schedule of Equity Method Investments [Line Items]          
Current assets 865.4 1,573.3 865.4 1,573.3  
Noncurrent assets 1,362.9 3,419.2 1,362.9 3,419.2  
Current liabilities 500.8 189.3 500.8 189.3  
Noncurrent liabilities 665.2 1,470.4 665.2 1,470.4  
Noncontrolling interests $ 2.1 $ 3.3 2.1 3.3  
Net sales     339.3 444.3 378.6
Gross profit (loss)     (125.7) (18.6) (14.1)
Net income (loss)     (2,466.0) (274.3) (1,775.3)
Net income (loss) attributable to CBI     $ (2,447.9) $ 328.7 $ (1,750.0)